A clinical trial is conducted to examine aspirin
in prevention of cardiovascular mortality
–10,000 subjects are randomized equally to receive either
aspirin or placebo
–Subjects
are randomized over a three year period
–Subjects are followed for fatal events for an additional
three year period following accrual of the last subject